Stephens Consulting, LLC Incyte Corp Transaction History
Stephens Consulting, LLC
- $422 Billion
- Q2 2025
A detailed history of Stephens Consulting, LLC transactions in Incyte Corp stock. As of the latest transaction made, Stephens Consulting, LLC holds 6 shares of INCY stock, worth $465. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6Holding current value
$465% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INCY
# of Institutions
705Shares Held
194MCall Options Held
564KPut Options Held
317K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.39 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.66 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.55 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.15 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$779 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $17.3B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...